- Celostátní registr pacientů s roztroušenou sklerózou ReMuS - význam sběru dat z reálně klinické praxe2017 | 1. lékařská fakulta
- ReMuS - český celostátní registr pacientů s roztroušenou sklerózou2016 | 1. lékařská fakulta
- Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registry2021 | 1. lékařská fakulta
- Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry2022 | 1. lékařská fakulta
- A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry2023 | 1. lékařská fakulta
- Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry2023 | 1. lékařská fakulta
- The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis2016 | 1. lékařská fakulta
- Defining secondary progressive multiple sclerosis2016 | 1. lékařská fakulta
- Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study2017 | 1. lékařská fakulta
- Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS2022 | 1. lékařská fakulta
- Cladribine versus fingolimod, natalizumab and interferon for multiple sclerosis2018 | 1. lékařská fakulta
- Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis2015 | 1. lékařská fakulta
- Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis2015 | 1. lékařská fakulta
- Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder2020 | 1. lékařská fakulta
- Delay from treatment start to full effect of immunotherapies for multiple sclerosis2020 | 1. lékařská fakulta
- Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS2017 | 1. lékařská fakulta
- Treatment Response Score to Glatiramer Acetate or Interferon Beta-1a2021 | 1. lékařská fakulta
- Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers2023 | 1. lékařská fakulta
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study2020 | 1. lékařská fakulta
- Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom2022 | 1. lékařská fakulta
- Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom2024 | 1. lékařská fakulta
- BREMSO: a simple score to predict early the natural course of multiple sclerosis2015 | 1. lékařská fakulta
- Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression2021 | 1. lékařská fakulta
- Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis2020 | 1. lékařská fakulta
- Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod2018 | 1. lékařská fakulta
- The effectiveness of natalizumab vs fingolimod-A comparison of international registry studies2021 | 1. lékařská fakulta
- Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study2019 | 1. lékařská fakulta
- Contribution of different relapse phenotypes to disability in multiple sclerosis2017 | 1. lékařská fakulta
- Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis2018 | 1. lékařská fakulta
- Multiple Sclerosis Relapses Following Cessation of Fingolimod2022 | 1. lékařská fakulta
